Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Protara Therapeutics, Inc. Director's Dealing 2018

Aug 2, 2018

34057_dirs_2018-08-02_966c3c04-9e9b-44a8-9d07-b12fdcc34859.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PROTEON THERAPEUTICS INC (PRTO)
CIK: 0001359931
Period of Report: 2018-08-01

Reporting Person: Hartman Bradley J (VP, People)

More from Protara Therapeutics, Inc.

Regulatory Filings 2026
May 28
Regulatory Filings 2026
May 13
Interim / Quarterly Report 2026
May 13
Regulatory Filings 2026
May 13
Regulatory Filings 2026
Mar 30
Regulatory Filings 2026
Feb 24
Regulatory Filings 2026
Feb 2
Director's Dealing 2026
Jan 27
Director's Dealing 2026
Jan 27
Director's Dealing 2026
Jan 27
View all filings →